UnknownNCT02802657
Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration
PHASE4 · 141 planned enrolment
- Countries listed
- 1
- Registry update
- May 19, 2020
Registry Intervention View
Conbercept
Trial registrations containing the exact intervention label Conbercept.
Exact registry label · Not reported
3 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
1 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT02577107
Head to Head Study of Anti-VEGF Treatment.
PHASE4 · 12 planned enrolment
- Countries listed
- 1
- Registry update
- November 30, 2017
UnknownNCT02098720
An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD)
PHASE2 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- July 22, 2014